1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
680C3F3F4E6082E6A85256EBC006B87B3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/building-stronger-strategic-alliances-for-new-pharmaceutical-product-planning
18
19
203.80.128.196
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing New Product Development and Launch Managing Development Process Cross-Functional Teams Team Structure

Building Stronger Strategic Alliances for New Pharmaceutical Product Planning

DB Image

ID: 4679


Features:


Pages/Slides: 7


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

This document helps pharmaceutical companies identify alliance opportunities that minimize problems in transition and maximize long-term benefits. Since top companies view alliances as long term relationships, it is important to cultivate and maintain these realtionships as strongly as possible. There are many obstacles, such as competition. Pharmaceutical companies will learn from this document how to leverage existing relationships, to gain a competitive advantage in product acquisition when new product alliance opportunities arise. This 7-page report details how successful alliances are formed and maintained.

Key Topics

  • Seeking Alliances
  • Indentify "Win-Win" Alliance Opportunities
  • Communicate Effectively to Maintain a Good Relationship
Sample Best Practices
  • Strengthen alliances through building relationships with potential partners
    * At one benchmark partner, the new product development group uses a database of research being conducted throughout the world to identify potential alliance partners.
  • Set clear objectives to improve long-term development of partnership relationships
    * One studied company highlighted “mutual goals” as a key success factor in its product partnerships.
  • Bundle strategic alliance opportunities to support efficiency.
    * Another studied benchmark company, for example, seeks to identify at least two licensing opportunities within a therapeutic area.
Methodology
The insights and best practices showcased in this report are distilled from lessons learned in interviews with executives and specialists who have extensive experience in designing and managing new product planning and strategic alliance departments at a range of pharmaceutical companies. This document originated from a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Eli Lilly; Pfizer; Amgen; Janssen


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.